In last trading session, Precigen Inc (NASDAQ:PGEN) saw 3.13 million shares changing hands with its beta currently measuring 1.84. Company’s recent per share price level of $1.31 trading at $0.03 or 2.34% at ring of the bell on the day assigns it a market valuation of $386.66M. That closing price of PGEN’s stock is at a discount of -65.65% from its 52-week high price of $2.17 and is indicating a premium of 50.38% from its 52-week low price of $0.65.

For Precigen Inc (PGEN), analysts’ consensus is at an average recommendation of Buy while assigning it a mean rating of 2.00. Splitting up the data highlights that, out of 2 analysts covering the stock, 0 rated the stock as a Sell while 0 recommended an Overweight rating for the stock. 0 suggested the stock as a Hold whereas 2 see the stock as a Buy. 0 analyst(s) advised it as an Underweight.

Precigen Inc (NASDAQ:PGEN) trade information

Upright in the green during last session for gaining 2.34%, in the last five days PGEN remained trading in the red while hitting it’s week-highest on Monday, 05/12/25 when the stock touched $1.31 price level, adding 11.49% to its value on the day. Precigen Inc’s shares saw a change of 16.96% in year-to-date performance and have moved -2.96% in past 5-day. Precigen Inc (NASDAQ:PGEN) showed a performance of -9.03% in past 30-days.

Wall Street analysts have assigned a consensus price target of 6 to the stock, which implies a rise of 78.17% to its current value. Analysts have been projecting 6 as a low price target for the stock while placing it at a high target of 6. It follows that stock’s current price would drop -358.02% in reaching the projected high whereas dropping to the targeted low would mean a loss of -358.02% for stock’s current value.

Precigen Inc (NASDAQ:PGEN)’s Major holders

PATIENT CAPITAL MANAGEMENT, LLC is the top institutional holder at PGEN for having 18.17 million shares of worth $28.72 million. And as of 2024-06-30, it was holding 7.2017 of the company’s outstanding shares.

The second largest institutional holder is BLACKROCK INC., which was holding about 10.25 million shares on 2024-06-30. The number of shares represents firm’s hold over 4.0604 of outstanding shares, having a total worth of $16.19 million.

On the other hand, Advisor Managed Portfolios-Patient Opportunity Trust and VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund are the top two Mutual Funds which own company’s shares. As of Mar 31, 2025, the former fund manager was holding 13.6 shares of worth $17.82 million or 4.61% of the total outstanding shares. The later fund manager was in possession of 5.45 shares on Dec 31, 2024, making its stake of worth around $7.14 million in the company or a holder of 1.85% of company’s stock.